Close X
Tuesday, November 26, 2024
ADVT 
International

At 42, Rishi Sunak youngest person to take UK PM office in over 200 years

Darpan News Desk IANS, 24 Oct, 2022 09:41 AM
  • At 42, Rishi Sunak youngest person to take UK PM office in over 200 years

London, Oct 24 (IANS) Conservative party's Rishi Sunak will become the first Hindu and the first person of colour to become Britain's Prime Minister. At the age of 42, he is also the youngest person to take the office in more than 200 years.

The result of Monday's contest caps a spectacularly rapid rise to the pinnacle of British politics, CNN reported.

Sunak was first elected as an MP in 2015 and spent two years on the backbenches, during which Brexit dominated the political agenda. Sunak supported leaving the EU during the 2016 referendum.

He subsequently became a junior minister in former Prime Minister Theresa May's government.

It was another former Prime Minister Boris Johnson who gave Sunak his first major government role when he first appointed him as the Chief Secretary to the Treasury in 2019, and as the Chancellor in 2020.

Sunak won popularity during the early weeks of the pandemic when he unveiled an extensive support plan for those unable to work during lockdown.

But the "Partygate" scandal that took down Boris Johnson also tarnished his reputation, and he became archrivals with Johnson after quitting his government earlier this year. Congratulations poured in from Indian PM Narendra Modi.

Sunak has remained tight-lipped on his policy plan in the last few days but he was widely seen as the more moderate of the two candidates in the last leadership contest over the summer. Compared to Liz Truss, he took a softer line on matters like Brexit and the economy, CNN reported.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK